fool.com
Search documents
Got $500? 3 Pharma Stocks to Buy and Hold Forever
fool.com· 2024-05-26 14:15
Core Investment Thesis - Investing in pharmaceutical stocks can yield significant returns if the right companies are selected and held long-term [1] Vertex Pharmaceuticals - Vertex Pharmaceuticals dominates the cystic fibrosis (CF) market, generating nearly $2.7 billion in sales in Q1, a 13% increase year-over-year [2][3] - The company has a strategy to access nearly all eligible CF patients and is developing additional therapies, minimizing R&D costs [2] - Vertex is also seeking FDA approval for its acute pain program, which could provide substantial revenue if successful, while its CF business remains a strong fallback [3] Eli Lilly - Eli Lilly is focused on cardiometabolic medicines, with its drugs Mounjaro and Zepbound generating significant sales, $1.8 billion and $517 million respectively in Q1 [4][5] - The company is in the process of developing new molecules for type 2 diabetes and obesity, and expanding indications for existing drugs to meet high demand [5] - Eli Lilly's production capabilities are currently unable to meet demand, indicating a bullish outlook for the stock as it works to catch up [5] Pfizer - Pfizer's strategy involves becoming a leader in oncology medicines through R&D, acquisitions, and collaborations, aiming for an additional $45 billion in annual revenue by 2030 [6][7] - The company expects 2024 revenue between $58.5 billion and $61.5 billion, potentially exceeding $100 billion annually by 2030 [7] - While ambitious, Pfizer's plans are supported by a history of successful execution, presenting a favorable risk-reward balance [7]
The AI Money Flow: Why You Can't Afford to Miss Stocks Like Nvidia and Snowflake
fool.com· 2024-05-26 13:03
Core Insights - The AI revolution, initiated by OpenAI's ChatGPT, is significantly impacting the stock market, with companies like Microsoft and Nvidia leading in market capitalization due to their involvement in generative AI [1] - The economic implications of AI are complex, potentially leading to both wealth creation and redistribution, raising questions about its broader societal effects [1] Group 1: AI Revenue Sources - A substantial portion of AI profits is derived from the sale of AI-enabling hardware, particularly high-end GPUs from companies like Nvidia, which are essential for training and deploying AI models [3] - AI-driven software and platforms, such as Microsoft's Azure cloud services, represent another major revenue source, with subscription models providing steady income and benefiting hardware manufacturers [4] - Consumer products increasingly incorporate AI, driving revenue through subscriptions, ads, and sales of smart devices, highlighting the importance of consumer spending in the AI ecosystem [5] - Businesses across various sectors are adopting AI to enhance operations and decision-making, creating significant value and leading to increased investments in AI technologies [6] Group 2: Future AI Revenue Streams - The development of autonomous systems, including vehicles and drones, is expected to create new markets and revenue streams, with companies like Tesla and Waymo at the forefront [9] - AI technologies are anticipated to spur the creation of new industries and services, such as AI-driven drug discovery and precision farming, contributing to long-term revenue growth [10] - Data monetization is crucial for AI efficiency, with companies that effectively harness data gaining a competitive edge, potentially through data-as-a-service models [11] Group 3: Wealth Creation and Redistribution - The generative AI boom is set to create significant wealth through various channels, but the distribution of this wealth may not be equitable, with potential societal impacts like job displacement [12] - A balanced approach to AI growth is essential to ensure sustainable economic development and widespread benefits, including investments in education and privacy protections [13]
The Best Dividend Stocks to Buy Right Now
fool.com· 2024-05-26 12:30
These two dividend stocks are solid buys in a frothy market.Dividend stocks can be boring, especially when AI-fueled stock gains are proliferating. Still, for long-term investors, buying sustainable dividend stocks with solid growth potential is a timeless strategy.Two dividend stocks worth buying right now are telecom giant AT&T (T 0.17%) and tech heavyweight International Business Machines (IBM 0.13%).Wireless and fiber growthWhile rival Verizon has been shedding wireless subscribers, AT&T has been consis ...
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
fool.com· 2024-05-26 12:10
AbbVie's returns haven't been great this year, but investors shouldn't overlook this promising growth stock.Nvidia (NVDA 2.57%) has been a great stock to own, and it could remain that way for long-term investors. However, the problem is that it's trading at nearly 40 times its future profits. At such a high valuation, it sets a high bar for the business and effectively prices in a lot of future growth already. It could make it difficult for the stock to continue to generate high returns. Even if it does, at ...
Is It Too Late to Buy Palo Alto Networks Stock?
fool.com· 2024-05-26 11:30
The cybersecurity giant's pivot to a new growth strategy shows promise.Shares of cybersecurity powerhouse Palo Alto Networks (PANW 3.26%) experienced a resurgence in recent weeks, rising past $300. That is, until May 20, when the company reported earnings for its fiscal third quarter, which ended April 30.Suddenly Palo Alto Networks stock plunged. Does this create a buying opportunity? Perhaps the drop signals a reason to avoid the stock? Answering these questions requires taking a deeper look into Palo Alt ...
These High-Yield Dividend Stocks See Value (and Growth) in This Overlooked Space
fool.com· 2024-05-26 11:19
Core Viewpoint - Energy infrastructure companies are increasingly investing in natural gas storage assets, recognizing their critical role in balancing supply and demand, which is expected to enhance dividend growth for these companies [1][2][13]. Group 1: Investment Activity - Leading infrastructure operators have been actively acquiring gas storage assets, which are often overlooked by investors, indicating a growing recognition of their value [2][3]. - Brookfield Infrastructure has invested a total of $310 million in North American gas storage assets over the past decade, taking a contrarian approach during market lows [3][4]. - Enbridge acquired two gas storage assets for a total of $628 million, enhancing its cash flow and supporting LNG export facilities [7][9]. - Williams made a significant acquisition of a gas storage portfolio for nearly $2 billion, integrating it into its pipeline network to support power and LNG markets [11]. Group 2: Financial Performance - Brookfield's gas storage business has achieved over 20% compound annual growth in funds from operations (FFO) over the last five years, generating over $240 million in annual EBITDA [4][5]. - Enbridge's acquisitions are expected to provide stable, growing cash flow, supporting its high-yielding dividend, which has been increased for nearly 30 consecutive years [9]. - Williams anticipates significant earnings growth from its new gas storage assets, contributing to a dividend increase of over 6% earlier this year, with a forward yield above 4.5% [12]. Group 3: Future Growth Potential - Brookfield sees opportunities for its gas storage assets to support renewable natural gas and hydrogen, indicating a positive outlook for future growth [5][6]. - The ongoing demand for natural gas storage is expected to provide Brookfield, Enbridge, and Williams with growing cash flow, enhancing their ability to increase dividends [13].
Is Alphabet a Good Dividend Stock?
fool.com· 2024-05-26 11:15
Group 1: Core Insights - Alphabet has initiated dividend payments for the first time, joining other tech giants like Salesforce and Meta Platforms [1] - The company has a market capitalization exceeding $2 trillion, enabling it to pay dividends [1] - Alphabet's free cash flow (FCF) in Q1 was $16.8 billion, significantly higher than IBM's $1.9 billion for the same period [2] Group 2: Financial Performance - Alphabet's total revenue in Q1 was $80.5 billion, with advertising sales contributing $61.7 billion [2] - YouTube generated $8.1 billion in advertising revenue in Q1, up from $6.7 billion the previous year [4] - Google Cloud sales reached $9.6 billion in Q1, an increase from $7.5 billion in 2023 [4] Group 3: Dividend Considerations - Alphabet's dividend is set at $0.20 per share, yielding 0.5%, which is lower than IBM's yield of 3.8% [5] - The company plans to pay quarterly cash dividends but lacks a historical track record for dividend increases [5] - Alphabet's competitive strength in the cloud market is notable, holding an 11% market share compared to IBM's 2% [6] Group 4: Growth Potential - Alphabet is investing in artificial intelligence, integrating it into its search engine and YouTube [6] - The company's strong financials, FCF generation, and rising revenue position it as an excellent growth stock despite its lower dividend yield [6]
Why Is Everyone Talking About Nvidia Stock?
fool.com· 2024-05-26 11:07
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy.Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...
Forget Realty Income: 2 High-Yield REIT Stocks to Buy Instead
fool.com· 2024-05-26 11:05
Realty Income is a great company, but it is a tortoise. You might want to consider Agree Realty and W.P. Carey instead.It would probably be a mistake to simply forget about net-lease giant Realty Income (O -0.25%). It is a well-run company, but it poses some problems for investors when you dig into the story a bit. For those looking for a bit more growth, competitors Agree Realty (ADC 0.53%) and W.P. Carey (WPC -0.96%) might be more attractive.I happily own Realty IncomeThere's nothing inherently wrong with ...
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
fool.com· 2024-05-26 10:53
The gold rush for obesity medications just got a bit more intense.With some promising clinical trial results in hand and more that could be on the way relatively soon, Amgen's (AMGN -0.21%) latest attempt to develop a therapy for obesity is looking like it could be a contender for the crown that's currently jointly held by the likes of Eli Lilly (LLY -0.13%) and Novo Nordisk (NVO 0.35%). Though it won't be competing with those two heavyweights directly until it finishes the clinical trials process, which co ...